Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Abuse-resistant amphetamine prodrugs










Image Number 14 for United States Patent #7662788.

The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.








 
 
  Recently Added Patents
Housing for gas flow indicator
Enhancement of semiconducting photovoltaic absorbers by the addition of alkali salts through solution coating techniques
Packaging for socks
Crowd control barrier II
Active element machine computation
Internal wiring structure of semiconductor device
Method and apparatus for monitoring and/or controlling the curing of cements used in medical procedures
  Randomly Featured Patents
Champagne cooling bucket or the like
Inkjet printhead assembly and method of assembling same
Microbial production of terephthalic acid and isophthalic acid
Softgel capsule
Method and system for communicating with remote units in a communication system
Lightweight superplastically formed, diffusion bonded panel structure and process of manufacture
Multi-function scaler for normalization of numbers
Multi-frame transmission control for token ring networks
System and method for re-aligning antennas
Treatment of arthritis with 3,5-dichloromethotrexate